The Best GLP-1 Telehealth Programs of 2026: Full Cost Comparison
Eight GLP-1 telehealth programs, eight different answers to the same question: what will this actually cost me by month twelve? We’ve reviewed every one of these services individually, and the headline price almost never matches the twelve-month reality. A $179 entry price that quietly climbs to $299 at maintenance doses. A $39 membership that doesn’t include the medication. A $129 plan that really does stay $129. This roundup of the best GLP-1 telehealth programs of 2026 puts all the numbers we’ve gathered in one table, then gives you the two-sentence honest verdict on each — so you can compare on dollars first and marketing never.
Quick housekeeping before the money: every program here prescribes compounded semaglutide or tirzepatide, and compounded medications are not FDA-approved the way brand-name Wegovy or Zepbound are. They come from licensed compounding pharmacies, but the FDA doesn’t review each version for safety and efficacy. Also, no reputable service guarantees a prescription — a licensed clinician reviews your intake and decides. Anyone promising the drug before the evaluation is a red flag, not a bargain. Worth the context too: roughly 42% of US adults meet the clinical threshold for obesity per NIH data, which is why this market exploded — and why sloppy operators followed the good ones in.
The full cost table: GLP-1 telehealth programs compared
Prices are what we documented in our individual reviews; promotions shift, so confirm at checkout.
| Program | Semaglutide (steady-state) | Tirzepatide | Dose-escalation policy | Standout term |
|---|---|---|---|---|
| Lttl | from $129/mo | from $199/mo | Flat at every dose | No contract; up to $140 off month one |
| TrimRx | ~$174/mo (12-mo prepay); $299 month-to-month | ~$349/mo | Tirzepatide flat at every dose | Nurse messaging and titration support included |
| Gala | — | $179/mo (yearly) or $199/mo (3-mo); $149 microdose | Dose adjustments cost nothing | Cheapest tirzepatide floor we’ve reviewed |
| Pallas Health | $139 first month, then ~$199/mo (billed $597/12 wks) | $179 first month, then ~$299/mo | Flat regardless of dose | Full refund if the clinician doesn’t approve you |
| BreezeMeds | $199/mo injection; ~$299 oral tablet | ~$399/mo (oral) | Bundle pricing; discounts revealed at checkout | Oral (no-needle) options for both drugs |
| MEDVi | ~$179 entry, climbing to $199–$299 with dose | ~$299/mo | Escalates as you titrate up | $50/mo senior discount at 65+ |
| Found | From ~$169/mo + $39–$99/mo membership; ~$349+ all-in | — | Medication billed separately from membership | Real coaching program, not just refills |
| Trimi | Cash-pay monthly, both drugs offered; quote comes after clinical intake | Not published pre-intake | Discloses its 503A pharmacies by name | |
The honest verdict on each program
Lttl owns the price floor. Semaglutide from $129 a month, flat at every dose, no contract, and shipping within about 48 hours — our Lttl semaglutide vs tirzepatide breakdown found the cheaper plan delivers the same brand-reported 32-pound six-month average as the $199 tirzepatide plan, which makes the $129 tier the single best dollars-per-pound number in this table.
TrimRx charges for hand-holding, and for the right person it’s worth it. Our TrimRx cost and coaching guide priced the support premium at roughly $50–$150 a month over bare-bones compounders — money well spent in week three when the nausea hits and you need a nurse’s answer by morning, mostly dead weight if you’re a second-year user who just needs refills.
Gala has the lowest tirzepatide entry we’ve seen from a legitimate service: $179 monthly on the yearly plan, with a $149 microdose tier for the side-effect-wary. The catch, per our Gala GLP-1 cost breakdown, is that the headline rate requires a twelve-month commitment to a drug you haven’t tried yet — we’d start on the $199 three-month plan instead.
Pallas Health wins on billing honesty. Flat pricing at every dose, no membership stacked on top, and — rare in this space — a full refund if the clinician decides GLP-1 therapy isn’t appropriate for you. Note from our Pallas Health cost review: after month one it bills quarterly ($597 or $897 at a time), so budget for the lump, not a smooth monthly charge.
BreezeMeds is the pick if needles are the dealbreaker — it’s one of the few offering both semaglutide and tirzepatide as daily oral tablets. Our BreezeMeds value guide liked the $199 injection price and disliked that multi-month discount amounts only appear once you reach checkout.
MEDVi is this table’s cautionary tale about entry pricing. The $179 headline drifts toward $299 as your dose climbs, which our MEDVi cost and care review calculated can erase the apparent savings over a flat-rate rival within a year. The senior discount is genuinely nice; the escalating structure is not.
Found is a different product wearing the same category label: a coaching-and-habits program with medication attached. Per our Found vs medication-only comparison, all-in maintenance cost lands near $349 a month — worth it if you’ve lost and regained weight repeatedly and know the drug alone won’t fix the pattern, skippable if you just want the prescription.
Trimi is the newest name here (founded 2024) and the most transparent about its supply chain, naming its 503A compounding pharmacies outright. It doesn’t publish pricing before the clinical intake, which we don’t love. Our Trimi review scored it 4.2/5 as a clean, accessible entry point for people comfortable doing their homework at quote time.
How to read these numbers before you commit
Three moves save the most money. First, always compute the twelve-month total at your likely maintenance dose — an escalating program’s month-one price is an advertisement, not a forecast. Second, prize flat-at-every-dose pricing: it’s the difference between a predictable $1,548 year (Lttl semaglutide) and a bill that grows every time your clinician adjusts you upward. Third, be suspicious of prepaying a full year of a medication your body hasn’t met. Gastrointestinal side effects push a real fraction of GLP-1 users off treatment in the first weeks, and a locked annual plan turns that bad month into a sunk cost. The one thing this table can’t tell you: whether any of these medications is right for your body. That call belongs to the prescribing clinician, not a comparison chart.
What’s the cheapest GLP-1 telehealth program in 2026?
Of the programs we’ve reviewed, Lttl’s $129/month flat-rate semaglutide plan is the lowest ongoing price, with Gala’s $149 tirzepatide microdose tier the cheapest tirzepatide route. Both hold their price as your dose increases, which matters more than the sticker over a full year.
Why is compounded semaglutide so much cheaper than Wegovy?
Brand-name Wegovy runs roughly $1,349 a month cash-pay, versus about $129–$299 for compounded versions. Compounding pharmacies produce the drug without the brand’s pricing or approval pathway — which is also the trade-off: compounded GLP-1s aren’t FDA-approved products, so you’re trading the agency’s per-product review for an enormous price gap.
Do these programs guarantee I’ll get a prescription?
No, and that’s a feature. Every legitimate service routes your intake to a licensed clinician who can decline to prescribe. Pallas is notable for refunding you fully in that case; with most others, check the refund terms before paying, because policies vary and some keep the intake fee either way.
Flat pricing vs escalating pricing — how much does it really matter?
A lot. Most people titrate from a starter dose to a higher maintenance dose within a few months. On an escalating program like MEDVi, that can move you from $179 to $299 a month — roughly $1,000 more over a year than a flat program at a similar entry price. If you compare only month-one prices, escalating programs will always look better than they are.
Affiliate & medical disclosure: This review is independent and for information only, not medical advice. Some links may be affiliate links; we may earn a commission at no cost to you, which never affects our score. Consult a licensed provider before starting any product.